检索结果-南通市图书馆

Molecular diagnosis and treatment of meningiomas:an expert consensus(2022)

在线全文

学校读者我要写书评

暂无评论

Chinese medical Journal 2022年第16期135卷 1894-1912页

作者： Jiaojao Deng Lingyang Hua Liuguan Bian Hong Chen Ligang Chen Hongwei Cheng Changwu Dou Dangmurenjiapu Geng Tao Hong Hongming Ji Yugang Jiang Qing Lan Gang Li Zhixiong Liu Songtao Qi Yan Qu Songsheng Shi Xiaochuan Sun Hajun Wang Yongping You Hualin Yu Shuyuan Yue Jianming Zhang Xiaohua Zhang Shuo Wang Ying Mao Ping Zhong Ye Gong Group of Neuro-Oncology Society of Neurosurgery Chinese medical Association department of Neurosurgery Huashan HospitalFudan UniversityShanghai 200040China National Center for Neurological Disorders Huashan HospitalFudan UniversityShanghai 200040China shanghai Key laboratory of Brain Function and Restoration and Neural Regeneration Shanghai 200040China Neurosurgical Institute of Fudan university Shanghai 200040China shanghai Clinical medical Center of Neurosurgery Shanghai 200040China department of Neurosurgery Rujn HospitalShanghai Jiao Tong University School of MedicineShanghai 200025China department of Pathology Huashan HospitalFudan UniversityShanghai 200040China department of Neurosurgery The Affiliated Hospital of Southwest Medical UniversityLuzhouSichuan 646000China department of Neurosurgery The First Affiliated Hospital of Anhui Medical UniversityHefeiAnhui 230022China department of Neurosurgery The Affiliated Hospital of Inner Mongolia Medical UniverstyHohoInner Mongolia 750306China department of Neurosurgery The First Affiliated Hospital of Xinjiang Medical UniversityUrumqiXinjang 830011China department of Neurosurgery The First Affiliated Hospital of Nanchang UniversityNanchangJiangxi 330006China department of Neurosurgery Shanxi Medical Universty Shanxi Provincial People's HospitaTaiyuanShanxi 030012China department of Neurosurgery The Second Xiangya HospitalCentral South UniversityChangshaHunan 410011China department of Neurosurgery The Second Affiliated Hospital of Soochow UniversitySoochowJjangsu 215004China Deparment of Neurosurgery Qiu HospitalCheeloo College of Medicine and Insttute of Brain and Brain-Inspired ScienceShandong University JinanShandong 25003China department of Neurosurger Xiangya HospitalCentral South UuniversitChangshaHunan 410008China department of Neurosurgery Nanfang HospitalSouthern Medical UniverstyGuangzhouGuangdong 510515China department of Neurosurgery Tangdu HospitalThe Fourth Miltay Medial UniverstXi'anShaanxi 710038China department of Neurosurgery Fujian Medial University fliated Union H

Meningiomas are the most common primary intracranial neoplasm with diverse pathological types and complicated clinical *** fifth edition of the WHO Classification of Tumors of the Central Nervous System(WHO CNS5),published in 2021,introduces major changes that advance the role of molecular diagnostics in *** follow the revision of WHO CNS5,this expert consensus statement was formed jointly by the Group of Neuro-Oncology,Society of Neurosurgery,Chinese medical Association together with neuropathologists and evidence-based *** consensus provides reference points to integrate key biomarkers into stratification and clinical decision making for meningioma patients.

关键词： Clinical diagnosis Expert consensus Meningioma Molecular subtyping Therapeutic treatment

慢性阻塞性肺疾病胸部CT检查及评价中国专家共识

在线全文

学校读者我要写书评

暂无评论

中华放射学杂志 2023年第6期57卷 600-607页

作者：中华医学会放射学分会心胸学组郑敏郭佑民刘士远范丽刘敏金晨望不详文空军军医大学西京医院放射诊断科西安710032 西安交通大学第一附属医院医学影像科西安710061 海军军医大学第二附属医院放射诊断科上海200003 中日友好医院放射诊断科

慢性阻塞性肺疾病(COPD)是全球关注的重大公共卫生问题,近年来胸部CT评价COPD的研究发展迅速,但缺乏一致性认识。为此,中华医学会放射学分会牵头组织心胸学组专家,参考国际COPD的诊疗现状,结合我国胸部CT临床实践,经反复讨论形成以下共... 详细信息

慢性阻塞性肺疾病(COPD)是全球关注的重大公共卫生问题,近年来胸部CT评价COPD的研究发展迅速,但缺乏一致性认识。为此,中华医学会放射学分会牵头组织心胸学组专家,参考国际COPD的诊疗现状,结合我国胸部CT临床实践,经反复讨论形成以下共识,包括COPD临床诊断,胸部CT检查前准备及扫描方案,胸部CT定性、定量、功能评价,COPD急性加重及合并症的胸部CT评价以及胸部CT结构化报告。

关键词：肺疾病,慢性阻塞性体层摄影术,X线计算机专家共识

在线全文

学校读者我要写书评

暂无评论

食管鳞癌术后随访中国胸外科专家共识

中国胸心血管外科临床杂志 2022年第2期29卷 141-149页

作者：陈龙奇李小飞傅剑华赵松李印毛友生柳硕岩于振涛谭黎杰李辉韩泳涛陈椿康明强胡坚李志刚李鹤成张仁泉徐世东张临友蔡开灿中国医师协会胸外科医师分会中国医药教育协会胸外科专业委员会四川大学华西医院胸外科成都610041 空军军医大学唐都医院胸外科西安710038 中山大学肿瘤防治中心胸外科广州510060 郑州大学第一附属医院胸外科郑州450052 中国医学科学院肿瘤医院胸外科北京100021 福建省肿瘤医院胸外科福州350014 中国医学科学院肿瘤医院深圳医院胸外科广东深圳518116 复旦大学附属中山医院胸外科上海200032 首都医科大学附属北京朝阳医院胸外科北京100020 电子科技大学附属肿瘤医院(四川省肿瘤医院)胸外科成都610041 福建医科大学附属协和医院胸外科福州350001 浙江大学医学院附属第一医院普胸外科杭州310003 上海市胸科医院胸外科上海200030 上海交通大学医学院附属瑞金医院胸外科上海200025 安徽医科大学第一附属医院胸外科合肥230022 哈尔滨医科大学附属肿瘤医院胸外科哈尔滨150081 哈尔滨医科大学附属第二医院胸外科哈尔滨150081 南方医科大学南方医院胸外科广州510515 不详

外科手术是食管鳞癌最重要的治疗手段之一,术后随访是早期发现和治疗复发转移的有效方法,可提高患者的生活质量,改善预后。本共识旨在完善我国的食管鳞癌术后随访方案,为规范随访提供参考,进一步提高我国食管癌规范化诊疗水平。

关键词：食管鳞癌术后随访专家共识

生物标志物用于体检人群心血管病风险评估的专家共识

在线全文

学校读者我要写书评

暂无评论

中华健康管理学杂志 2022年第8期16卷 505-519页

作者：中华医学会健康管理学分会中华医学会检验医学分会中国医师协会心血管内科医师分会曾强王传新徐亚伟胡荣曲鹏宋震亚汪道文郑磊周洲不详解放军总医院第二医学中心健康管理研究院国家老年疾病临床医学研究中心北京100853 山东大学第二医院检验医学中心济南250199 上海市第十人民医院心血管内科上海200070 首都医科大学附属北京安贞医院健康管理中心大连医科大学附属第二医院心内科浙江大学医学院附属第二医院健康管理中心华中科技大学同济医学院附属同济医院心血管内科南方医科大学南方医院检验医学科中国医学科学院阜外医院实验诊断中心

心血管病是长期威胁我国居民生命和健康的重大卫生问题,其死亡人数占据我国疾病首位。做好心血管病一级预防,筛查出心血管病中高危人群进行强化干预势在必行。目前我国心血管病一级预防指南建议首先评估动脉粥样硬化性心脏病(ASCVD)和... 详细信息

心血管病是长期威胁我国居民生命和健康的重大卫生问题,其死亡人数占据我国疾病首位。做好心血管病一级预防,筛查出心血管病中高危人群进行强化干预势在必行。目前我国心血管病一级预防指南建议首先评估动脉粥样硬化性心脏病(ASCVD)和总心血管病10年发病风险,评定为心血管病高危个体的进行强化干预;对于中危个体,如年龄<55岁且10年风险为中危的个体再进行心血管病余生风险评估,并结合风险增强因素进一步确定是否为心血管病高危个体,以制定干预措施。生物标志物异常作为心血管病风险增强因素之一,在心血管疾病的风险分层、诊断、治疗及预后评估方面发挥着重要作用。为进一步明确生物标志物在心血管健康管理中的作用,提高医学工作者对生物标志物用于心血管疾病风险管理的意识,由中华医学会健康管理学分会、中华医学会检验医学分会和中国医师协会心血管内科医师分会牵头组织国内多学科专家,汇总国内外临床指南及最新研究证据,总结生物标志物用于体检人群的心血管病风险评估证据和路径,制定了本共识。本共识总结了可用于以及潜在可用于心血管病风险评估的生物标志物,重点归纳了基于两种证据质量高的生物标志物——高敏心肌肌钙蛋白和B型利钠肽的心血管健康筛查路径,并概括了相应的心血管病风险管理与干预措施,旨在促进多学科合作,共同推进心血管病风险筛查和健康管理,为我国心血管病一级预防作出贡献。

关键词：生物标志物心血管病风险评估体格检查健康管理

便携式肺功能仪原理、质控及临床应用的中国专家共识

在线全文

学校读者我要写书评

暂无评论

中华结核和呼吸杂志 2022年第10期45卷 970-979页

作者：中华医学会呼吸病学分会肺功能学组宋元林郑劲平陈智鸿李丽郭健高怡不详复旦大学附属中山医院呼吸与危重症医学科上海200032 广州医科大学附属第一医院呼吸与危重症医学科广州510120 复旦大学附属中山医院上海市肺科医院广州医科大学附属第一医院

便携式肺功能仪相较于传统实验室肺功能仪具有小型、便携、操作简便和造价低廉的优势。它可作为实验室肺功能仪的补充, 适用于社区、基层等卫生机构。目前, 国内尚缺乏便携式肺功能仪相关的指导性文件, 本专家共识将从设备硬件、设备质... 详细信息

便携式肺功能仪相较于传统实验室肺功能仪具有小型、便携、操作简便和造价低廉的优势。它可作为实验室肺功能仪的补充, 适用于社区、基层等卫生机构。目前, 国内尚缺乏便携式肺功能仪相关的指导性文件, 本专家共识将从设备硬件、设备质量要求, 操作要领、操作质控、临床应用和人员培训等几方面进行阐述。便携式肺功能仪由肺量计和计算机系统组成。它的核心部件是流量传感器, 其保留了实验室肺功能仪的核心功能即常规通气功能、舒张试验, 但不具备测定肺容积、残气量和弥散功能的能力。便携式肺功能仪产品需通过国家和国际权威机构的质量检测, 需达到ISO26782:2009的标准。便携式肺功能仪的质控包括设备质控、操作过程质控、报告质控等, 其技术细节与实验室肺功能仪的质控要求一致。它可用于呼吸疾病早筛、流行病学调查、体检筛查、临床试验、呼吸慢病管理及行动不便者床旁检查等。便携式肺功能仪器的操作技术培训主要针对基层社区医务工作者, 培训方式灵活多样, 注重理论和实践操作相结合。便携式肺功能仪具备实验室肺功能仪没有的一些高科技技术, 如数据智能传输、云数据库、大数据管理、生物传感器等, 这些技术的应用将使肺功能仪更加智能化和多元化, 也将极大提升呼吸慢病管理的水平。

关键词：生物传感器云数据库肺功能仪国际权威机构慢病管理流量传感器高科技技术指导性文件

Folic Acid Supplementation in Chinese Periconceptional Population:Results from the SPCC Study

在线全文

学校读者我要写书评

暂无评论

Biomedical and Environmental Sciences 2020年第8期33卷 557-565页

作者： WANG Ding Mei ZHANG Yi JIANG Yuan YE Ying HUANG Xiang Yuan LI Meng Ru JI Mi ZHAO Zheng Shan CHEN Xiao Tian SHENG Wei MA Xiao Jing ALLEN Stephen WANG Duo Lao YAN Wei Li HUANG Guo Ying 无 Children's hospital of Fudan university Shanghai 201102China shanghai Key laboratory of Birth Defect Shanghai 201102China department of Clinical Sciences Liverpool School of Tropical MedicineLiverpool L35QAUnited Kingdom the shanghai PreConception Cohort Group

Objective To determine the prevalence and determinants of folic acid(FA)supplementation in Chinese couples planning for pregnancy and in women during early *** This was a cross-sectional study based on the shanghai PreConception Cohort(SPCC)*** on FA supplementation and socio-demographic features were collected using *** visiting clinics for pre-pregnancy examination and pregnant women atshanghai,china,between March 2016 and September *** Among the pregnancy planners,42.4%(4,710/11,099)women and 17.1%(1,377/8,045)men used FA supplements,while 93.4%(14,585/15,615)of the pregnant women used FA *** supplement use was higher in female pregnancy planners who were older(RR:1.13,95%CI:1.08–1.18),had higher education(RR:1.71,95%CI:1.53–1.92),and were residing in urban districts(RR:1.06,95%CI:1.01–1.11)of FA supplementation;female pregnancy planners with alcohol consumption(RR:0.95,95%CI:0.90–0.99)had lower odds of FA *** early pregnancy,women with higher educational level(RR:1.04,95%CI:1.03–1.06),who underwent pre-pregnancy examination(RR:1.02,95%CI:1.01–1.03)had higher odds of using an FA supplement;older aged(RR:0.99,95%CI:0.98–0.99),and multigravida(RR:0.97,95%CI:0.96–0.98)had lower odds of FA *** Although the majority of pregnant women took FA supplements,more than half of the women planning for pregnancy did *** strategies are needed to improve pre-conception FA supplementation.

关键词： Folic acid supplementation Peri-conception Birth defects china Pregnancy

Digestive tract reconstruction in pancreaticoduodenectomy in university hospitals of china: a national questionnaire survey

在线全文

学校读者我要写书评

暂无评论

Journal of Pancreatology 2022年第4期5卷 127-152页

作者： Jishu Wei Qiang Xu Yuhua Zhang Jiabin Jin Xiaodong Tian Qiaofei Liu Zipeng Lu Zheng Wang Shanmiao Gou Song Gao Xianlin Han Yefei Rong Niandong Ji Ye Lin Guolin Li Shi Chen Feng Cao Hua Chen Wenming Wu Yupei Zhao the Young Elite Pancreatic Surgery Club of china Pancreas Center The First Affiliated Hospital of Nanjing Medical UniversityNanjing department of General Surgery State Key Laboratory of Complex and Rare DiseasesPeking Union Medical College HospitalChinese Academy of Medical Science and Peking Union Medical CollegeBeijing department of Hepatobiliary and Pancreatic Surgery The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)Institute of Basic Medicine and Cancer(IBMC)Chinese Academy of SciencesHangzhou department of General Surgery Pancreatic Disease CenterRuijin HospitalShanghai Jiao Tong University School of MedicineShanghai department of General Surgery Peking University First HospitalBeijing department of Hepatobiliary Surgery the First Affiliated Hospital of Xi’an Jiaotong UniversityPancreas Center of Xi’an Jiaotong University department of Pancreatic Surgery Union HospitalHuazhong University of Science and TechnologyWuhan department of Pancreatic Carcinoma Tianjin Medical University Cancer Hospital and InstituteTianjin department of pancreatic surgery Zhongshan HospitalFudan UniversityShanghai department of General Surgery Xiangya HospitalCentral South UniversityChangsha department of Hepatobiliary Surgery Guangdong Provincial People's HospitalGuangdong Academy of Medical SciencesGuangzhou department of Hepatobiliary Pancreatic and Splenic Surgerythe Sixth Affiliated Hospital of Sun Yat-sen UniversityGuangzhou department of Hepato-biliary-pancreatic Surgery Fujian Provincial HospitalFuzhou department of General Surgery Xuanwu HospitalCapital Medical UniversityBeijing department of Pancreatic and Biliary Surgery Harbin Medical UniversityHarbin 不详

Background Pancreaticoduodenectomy(PD)has been widely applied in general hospitals in china;however,there is still a lack of unified standards for each surgical technique and *** survey is intended to investigate the current status of digestive tract reconstruction after PD in university hospitals in *** A cross-sectional survey was conducted among the members of the Young Elite Pancreatic Surgery Club of china by using the Questionnaire for Digestive Tract Reconstruction after *** questionnaire was disseminated and collected by point-to-point communication via WeChat public *** A total of 73 valid questionnaires were returned from 65 university hospitals in 28 provincial divisions of china's *** respondents who performed PD surgery with an annual volume of over 100 cases accounted for 63%.Generally,laparoscopic PD was performed less often than open *** and Whipple reconstructions accounted for 70%and 26%,*** sequence of pancreatoenteric,biliary-enteric,and gastrointestinal reconstruction accounted for 84%of *** pancreatoenteric anastomosis,double-layer anastomosis is the most commonly employed type,accounting for approximately 67%,while single-layer anastomosis accounts for 30%.Of the double-layer anastomoses,duct-to-mucosa/dunking(94%/4%)PJ was performed with duct-mucosa using the Blumgart method(39%)and Cattel-Warren(29%),with continuous/interrupted sutures in the inner layer(69%/31%)and continuous/interrupted sutures in the outer layer(53%/23%).In single-layer anastomosis,continuous/interrupted sutures accounted for 41%/45%.In hepatojejunostomy,single-layer/double-layer suture accounted for 79%/4%,and continuous/interrupted suture accounted for 75%/9%.Forty-six percent of the responding units had not applied double-layer biliary-intestinal anastomosis in the last 3 years,75%of the responding surgeons chose the anastomosis method according to bile duct diameter,with absorbab

关键词： Pancreaticoduodenectomy Digestive tract reconstruction university hospitals Questionnaire survey

“三医联动”下的武警医院门诊药占比情况分析

在线全文

学校读者我要写书评

暂无评论

武警医学 2018年第1期29卷 48-51页

作者：汤元杰刘沛钟仕洋李阳武警江苏总队医院泌尿外科扬州225003 海军军医大学数理教研室上海200433 武警江苏总队医院体检科扬州225003 海军军医大学卫生事业管理学教研室上海200433

目的根据公立医院"取消药物加成"的改革目标,重点分析我院门诊总费用的结构及门诊药占比,为军队医院参与城市公立医院改革提供决策依据。方法收集武警江苏总队医院2005-2015年门诊就诊人次,采用SAS 9.3软件及STATA 12对次均门诊费用、... 详细信息

目的根据公立医院"取消药物加成"的改革目标,重点分析我院门诊总费用的结构及门诊药占比,为军队医院参与城市公立医院改革提供决策依据。方法收集武警江苏总队医院2005-2015年门诊就诊人次,采用SAS 9.3软件及STATA 12对次均门诊费用、次均药物费用、药占比进行数据分析并进行研究。结果 (1)门诊总费用中药物费用所占比例最高,为38.0%,11年间大致呈现"凹"型趋势,其次为检查费27.0%,且呈现逐年递增趋势;(2)2005-2015年各年门诊药占比均低于当年统计年鉴公布的数据,即低于国家同期平均水平,且药占比上升趋势无统计学意义(Z=-1.39,P=0.164);(3)男、女患者次均药物费用均呈现缓慢增长趋势,且男性患者次均药物费用、药占比分别为101.3元和35.1%,高于女性患者的78.7元和30.8%,男、女患者门诊药费差异有统计学意义(Z=-49.1429,P38.7%,35~59岁年龄组患者次均药物费用年均增长率最快,不同年龄组患者的门诊药费差异有统计学意义(χ2=4206.1403,P<0.001)。结论该院根据实际情况制定的政策起到了控制药占比的作用,但药费仍持续上涨,可借鉴采取"三医联动"形式控制药物费用,并将军队医院纳入地方医改,这是促进其持续发展源动力。

关键词：药占比次均药物费年均增长率

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline(updated version)

在线全文

学校读者我要写书评

暂无评论

military medical Research 2020年第3期7卷 249-282页

作者： Ying-Hui Jin Qing-Yuan Zhan Zhi-Yong Peng Xue-Qun Ren Xun-Tao Yin Lin Cai Yu-Feng Yuan Ji-Rong Yue Xiao-Chun Zhang Qi-Wen Yang Jianguang Ji Jian Xia Yi-Rong Li Fu-Xiang Zhou Ya-Dong Gao Zhui Yu Feng Xu Ming-Li Tu Li-Ming Tan Min Yang Fang Chen Xiao-Ju Zhang Mei Zeng Yu Zhu Xin-Can Liu Jian Yang Dong-Chi Zhao Yu-Feng Ding Ning Hou Fu-Bing Wang Hao Chen Yong-Gang Zhang Wei Li Wen Chen Yue-Xian Shi Xiu-Zhi Yang Xue-Jun Wang Yan-Jun Zhong Ming-Juan Zhao Bing-Hui Li Lin-Lu Ma Hao Zi Na Wang Yun-Yun Wang Shao-Fu Yu Lu-Yao Li Qiao Huang Hong Weng Xiang-Ying Ren Li-Sha Luo Man-Ru Fan Di Huang Hong-Yang Xue Lin-Xin Yu Jin-Ping Gao Tong Deng Xian-Tao Zeng Hong-Jun Li Zhen-Shun Cheng Xiao-Mei Yao Xing-Huan Wang Center for Evidence-Based and Translational medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Respiratory Diseases China-Japan Friendship HospitalBeijing 100029China department of Pulmonary and Critical Care medicine China-Japan Friendship HospitalBeijing 10029China Leishenshan hospital in Wuhan Wuhan 430200China department of Critical Care medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Institutes of Evidence-based medicine and Knowledge Translation Henan UniversityKaifeng 475000HenanChina department of medical Imaging Guizhou Provincial People’s HospitalGuiyang 550002China departments of Orthopedics Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Hepatobiliary Surgery Zhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China department of Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China department of Radiology Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Clinical laboratory Peking Union Medical College Hospital(PUMCH)Peking Union Medical CollegeChinese Academy of Medical Sciences(CAMS)Beijing 100730China Center for Primary Health Care Research Lund University and Region Skåne25002 MalmöSweden Emergency Center Zhongnan Hospital of Wuhan UniversityWuhan 403371China department of Allergology Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Radiation and medical Oncology Zhongnan Hospital of Wuhan UniversityWuhan 43071China department of Critical Care medicine Renmin Hospital of Wuhan UniversityWuhan 430060China department of Emergency medicine and Chest Pain Center Qilu Hospital of Shandong UniversityJinan 250002China department of Respiratory and Critical Care medicine Suizhou Central HospitalHubei University of MedicineSuizhou 441300HubeiChina department of Clinic Pharmacy Second People’s Hospital of Huaihua Ci

The novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is the cause of a rapidly spreading illness,coronavirus disease 2019(COVID-19),affecting more than seventeen million people around the *** and treatment guidelines for clinicians caring for patients are *** the early stage,we have issued"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(standard version)";now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based *** formed a working group of clinical experts and *** steering group members proposed 29 questions that are relevant to the management of COVID-19 covering the following areas:chemoprophylaxis,diagnosis,treatments,and discharge *** searched the literature for direct evidence on the management of COVID-19,and assessed its certainty generated recommendations using the Grading of Recommendations,Assessment,Development and Evaluation(GRADE)*** were either strong or weak,or in the form of ungraded consensus-based ***,we issued 34 *** them,6 were strong recommendations for,14 were weak recommendations for,3 were weak recommendations against and 11 were ungraded consensus-based *** covered topics of chemoprophylaxis(including agents and Traditional Chinese medicine(TCM)agents),diagnosis(including clinical manifestations,reverse transcription-polymerase chain reaction(RT-PCR),respiratory tract specimens,IgM and IgG antibody tests,chest computed tomography,chest X-ray,and CT features of asymptomatic infections),treatments(including lopinavirritonavir,umifenovir,favipiravir,interferon,remdesivir,combination of antiviral drugs,hydroxychloroquine/chloroquine,interleukin-6 inhibitors,interleukin-1 inhibitors,glucocorticoid,qingfei paidu decoction,lianhua qingwen granules/capsules,convalescent plasma,lung

关键词： COVID-19 SARS-CoV-2 Recommendation Chemoprophylaxis Diagnosis Treatment Discharge management Traditional Chinese medicine guideline